shutterstock-190644512
30 January 2015AmericasBob Stembridge

Global patents: innovation leads to growth

Life sciences companies do not do research and development (R&D) like everyone else. With longer innovation cycles, several well-defined layers of regulatory approval and various global hurdles to overcome, patent volumes in the pharmaceutical industry are often dwarfed by those of fast-moving industries such as semiconductors and consumer electronics, which tend to steal the spotlight when it comes to showcasing innovation.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
14 May 2026   Isomorphic Labs said the funding round, led by venture firm Thrive Capital, would be used to further its drug design engine and support hiring targets.
Americas
14 May 2026   The agreement is the latest in a string of major deals between Hengrui and multinational drugmakers, and will see the parties jointly develop assets while licensing others.
Americas
13 May 2026   PureWick claims that two rivals infringed its external catheter and urine-management technology in their medical devices.